We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

52 hedge funds and large institutions have $44.6M invested in Corvus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

136% more capital invested

Capital invested by funds: $18.9M → $44.6M (+$25.7M)

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

41% more funds holding

Funds holding: 3752 (+15)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less call options, than puts

Call options by funds: $266K | Put options by funds: $272K

2.79% less ownership

Funds ownership: 44.65%41.86% (-2.8%)

Holders
52
Holders Change
+15
Holders Change %
+40.54%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
11
Reduced
6
Closed
7
Calls
$266K
Puts
$272K
Net Calls
-$6K
Net Calls Change
-$15K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
51
Parallel Advisors
California
$46
Barclays
52
Barclays
United Kingdom
$2
Millennium Management
53
Millennium Management
New York
-$1.85M -2,029,423 Closed
DCM
54
Discovery Capital Management
Connecticut
-$499K -548,727 Closed
LP
55
LMR Partners
United Kingdom
-$27.3K -30,000 Closed
BBA
56
Baader Bank Aktiengesellschaft
Germany
-$17.7K -24,911 Closed
Mercer Global Advisors
57
Mercer Global Advisors
Colorado
-$10K -10,550 Closed
Envestnet Asset Management
58
Envestnet Asset Management
Illinois
-$9.55K -10,500 Closed
TWA
59
TCI Wealth Advisors
Arizona
-$455 -500 Closed